Table 2b.
Inpatient pain management pathway dosing: Partial agonists
| Drug | Route | Dose | Frequency |
|---|---|---|---|
| Buprenorphine | IVP | 0.15–0.3 mg | Q6 hr PRN |
| Buprenorphine (Subutex) | SL | 2–8 mg | Q6–8 hr |
| Buprenorphine-naloxone (Suboxone) | SL | 2–0.5 mg, 8–2 mg | Q6–8 hr |
Inpatient pain management pathway dosing: Partial agonists
| Drug | Route | Dose | Frequency |
|---|---|---|---|
| Buprenorphine | IVP | 0.15–0.3 mg | Q6 hr PRN |
| Buprenorphine (Subutex) | SL | 2–8 mg | Q6–8 hr |
| Buprenorphine-naloxone (Suboxone) | SL | 2–0.5 mg, 8–2 mg | Q6–8 hr |